Candel Therapeutics Inc.
CADL | NASDAQ
$11.69
+$0.48 (+4.28%)
Sep 22, 2026, 11:30 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31K | 62K | 93K | 124K | 124K | 124K | 124K | 124K | 124K | 124K | 124K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31K | 62K | 93K | 124K | 124K | 124K | 124K | 124K | 124K | 124K | 403K |
Operating Income | -71.99M | -56.42M | -48.27M | -40.66M | -36.21M | -33.6M | -33.37M | -35.55M | -35.65M | -36.66M | -38.39M | -36.17M | -36.19M | -35.37M | -34.72M | -34.36M | -33.51M | -30.06M | -25.73M | -24.11M | -18.83M | -16.15M |
Interest Income | 5.05M | 4.3M | 3.92M | 3.1M | 2.39M | 1.7M | 1.09M | 1.21M | 1.48M | 1.69M | 2.08M | 1.67M | 1.51M | 1.12M | 413K | 413K | 70K | n/a | n/a | 49K | 90K | 184K |
Pretax Income | -88.53M | -54.42M | -38.18M | -22.76M | -22.14M | -39.58M | -55.18M | -52.2M | -49.99M | -37.37M | -37.94M | -31.93M | -32.18M | -26.72M | -18.79M | -12.12M | -19.59M | -32.52M | -36.12M | -48.2M | -34.59M | -20.39M |
Net Income | -88.53M | -54.42M | -38.18M | -22.76M | -22.14M | -39.58M | -55.18M | -52.2M | -49.99M | -37.37M | -37.94M | -31.93M | -32.18M | -26.72M | -18.79M | -12.12M | -19.59M | -32.52M | -36.12M | -48.2M | -34.59M | -20.39M |
Selling & General & Admin | 22.86M | 20.1M | 17.77M | 16.37M | 14.97M | 14.37M | 14.06M | 13.79M | 13.47M | 13.52M | 13.89M | 13.99M | 14.51M | 14.62M | 14.06M | 14.82M | 14.07M | 12.35M | 10.69M | 9.39M | 7.56M | 6.38M |
Research & Development | 49.13M | 36.32M | 30.5M | 24.29M | 21.24M | 19.23M | 19.31M | 21.76M | 22.18M | 23.14M | 24.51M | 22.22M | 21.75M | 20.84M | 20.79M | 19.67M | 19.56M | 17.83M | 15.16M | 14.84M | 11.39M | 9.9M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -48K | -48K | -48K | -48K | -149K | -149K | -754K | -945K | -947K | -1.1M | -652K |
Operating Expenses | 71.99M | 56.42M | 48.27M | 40.66M | 36.21M | 33.6M | 33.37M | 35.55M | 35.65M | 36.66M | 38.39M | 36.16M | 36.21M | 35.41M | 34.8M | 34.34M | 33.48M | 29.43M | 24.91M | 23.29M | 17.86M | 15.62M |
Interest Expense | 4.72M | 3.38M | 2.12M | 1.09M | 1.42M | 1.75M | 2.09M | 2.37M | 2.56M | 2.63M | 2.6M | 1.92M | 1.77M | 1.56M | 1.13M | 1.14M | 621K | 201K | 38K | 27K | 27K | 12K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 71.99M | 56.42M | 48.27M | 40.66M | 36.21M | 33.6M | 33.37M | 35.55M | 35.65M | 36.66M | 38.39M | 36.16M | 36.21M | 35.41M | 34.8M | 34.34M | 33.48M | 29.43M | 24.91M | 23.29M | 17.86M | 15.62M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 74.13M | 62.36M | 54.9M | 54.89M | 51.49M | 31.68M | 35.56M | 32.01M | 29.88M | 29.2M | 28.98M | 28.92M | 28.92M | 28.92M | 28.9M | 28.89M | 28.81M | 28.69M | 23.33M | 23.33M | 24.8M | 18.71M |
Shares Outstanding (Diluted) | 74.13M | 62.36M | 54.9M | 54.89M | 51.49M | 31.68M | 35.56M | 32.01M | 29.88M | 29.2M | 28.98M | 28.92M | 28.92M | 28.92M | 28.9M | 28.89M | 28.81M | 28.69M | 23.33M | 23.33M | 24.8M | 18.71M |
EPS (Basic) | -1.41 | -0.98 | -0.61 | -0.47 | -0.59 | -1.24 | -1.75 | -1.73 | -1.69 | -1.28 | -1.30 | -1.10 | -1.10 | -0.91 | -0.64 | -0.39 | -0.79 | -1.34 | -1.55 | -2.18 | -1.63 | -1.09 |
EPS (Diluted) | -1.41 | -0.98 | -0.61 | -0.47 | -0.59 | -1.24 | -1.75 | -1.73 | -1.69 | -1.28 | -1.30 | -1.10 | -1.10 | -0.91 | -0.64 | -0.39 | -0.79 | -1.34 | -1.55 | -2.18 | -1.63 | -1.09 |
EBITDA | -60.47M | -50.3M | -35.22M | -20.74M | -19.74M | -36.84M | -52.1M | -48.83M | -46.44M | -33.75M | -34.38M | -32.04M | -32.49M | -27.28M | -28.14M | -18.53M | -26.73M | -27.89M | -23.51M | -31.26M | -17.65M | -15.41M |
EBIT | -60.98M | -51.05M | -36.06M | -21.67M | -20.72M | -37.83M | -53.09M | -49.83M | -47.43M | -34.73M | -35.34M | -32.98M | -33.38M | -28.12M | -28.92M | -19.26M | -27.26M | -28.24M | -23.72M | -31.3M | -17.73M | -15.5M |
Depreciation & Amortization | 507K | 749K | 845K | 927K | 977K | 984K | 990K | 994K | 994K | 981K | 960K | 932K | 892K | 843K | 778K | 735K | 530K | 350K | 211K | 39K | 84K | 85K |
Add to Watchlist
Select watchlists to add or remove CADL